eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2005, Volume 1, Issue 2 : 93-98 doi: ijmmas.2005.93.98
Research Article
Embryonic Cell Fate Predetermination in Neuronal and Ligodendrocyte Degeneration
Published
June 30, 2005
Abstract

Neuronal cell loss as preprogrammed pathways of cascade type might implicate such systems as oxidative stress in a setting of embryonic fate determination. Such programmed selectivity in neuronal susceptibility in diseases ranging from amyotrophic lateral sclerosis to Parkinson’s disease and Alzheimer type dementia might integrally recategorize neurodegenerative states that evolve in terms of embryonic attributes of cell types and subtypes. Even multiple sclerosis as an apparent dichotomy of direct myelin damage and of an evolving pattern of oligodendrocyte loss might implicate systems such as cell lysis in terms of predetermined embryonic attributes of the oligodendrocyte that responds to injury. It is in terms of neuronal and glial participation of cell fate determination and response that one may account for a dual occurrence of familial and sporadic variants of disease entities that progress both as patterns of disease manifestation and as system progression of lesions in neurodegeneration or demyelination.

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Impact of Climate Change on Human Health
20-26
Mental Health Awareness and Help-Seeking Behavior: A Comprehensive Study of Knowledge, Attitudes, Barriers, and Interventions
7-12
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Clinical Efficacy of Drug-Eluting Stents Among Hypertensive Patients
41-45
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.